Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Inventory (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of Inventory data on record, last reported at $5.7 million in Q3 2025.

  • For Q3 2025, Inventory fell 27.76% year-over-year to $5.7 million; the TTM value through Sep 2025 reached $5.7 million, down 27.76%, while the annual FY2024 figure was $8.4 million, 1555.12% up from the prior year.
  • Inventory reached $5.7 million in Q3 2025 per TNXP's latest filing, down from $6.0 million in the prior quarter.
  • Across five years, Inventory topped out at $13.7 million in Q2 2023 and bottomed at $508000.0 in Q4 2023.
  • Average Inventory over 3 years is $8.6 million, with a median of $8.3 million recorded in 2024.
  • The widest YoY moves for Inventory: up 1555.12% in 2024, down 40.44% in 2024.
  • A 3-year view of Inventory shows it stood at $508000.0 in 2023, then surged by 1555.12% to $8.4 million in 2024, then plummeted by 31.86% to $5.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $5.7 million in Q3 2025, $6.0 million in Q2 2025, and $8.1 million in Q1 2025.